⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
TRIVENI - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.4
| Stock Code | TRIVENI | Market Cap | 7,395 Cr. | Current Price | 338 ₹ | High / Low | 468 ₹ |
| Stock P/E | 23.4 | Book Value | 141 ₹ | Dividend Yield | 0.74 % | ROCE | 9.01 % |
| ROE | 8.32 % | Face Value | 1.00 ₹ | DMA 50 | 370 ₹ | DMA 200 | 371 ₹ |
| Chg in FII Hold | 1.26 % | Chg in DII Hold | 0.16 % | PAT Qtr | 109 Cr. | PAT Prev Qtr | 31.9 Cr. |
| RSI | 27.4 | MACD | -9.04 | Volume | 7,30,266 | Avg Vol 1Wk | 3,43,848 |
| Low price | 305 ₹ | High price | 468 ₹ | PEG Ratio | -1.69 | Debt to equity | 0.17 |
| 52w Index | 20.3 % | Qtr Profit Var | 92.0 % | EPS | 13.7 ₹ | Industry PE | 11.1 |
📊 Financials
- Revenue Growth: Strong, PAT improved to 109 Cr from 31.9 Cr
- Profit Margins: EPS at 13.7 ₹, showing moderate profitability
- Debt Ratios: Debt-to-equity at 0.17, low leverage
- Cash Flows: Healthy, supported by profit growth
- Return Metrics: ROCE 9.01% and ROE 8.32% indicate modest efficiency
💹 Valuation
- P/E Ratio: 23.4, higher than industry average (11.1), suggesting premium valuation
- P/B Ratio: ~2.4 (Current Price / Book Value), moderate
- PEG Ratio: -1.69, reflecting weak growth prospects
- Intrinsic Value: Slightly overvalued compared to peers
🏢 Business Model & Health
- Business Model: Sugar and engineering solutions, diversified across industrial sectors
- Competitive Advantage: Strong domestic presence, but cyclical demand impacts performance
- Overall Health: Financially stable with improving profits, though efficiency remains low
🎯 Entry Zone Recommendation
- Entry Zone: Attractive near 320–340 ₹ levels (close to current support)
- Long-Term Holding: Suitable for cautious investors; dividend yield (0.74%) adds minor stability
✅ Positive
- Quarterly PAT improved significantly (109 Cr vs 31.9 Cr)
- EPS of 13.7 ₹ reflects profitability
- FII holdings increased (+1.26%), showing foreign investor confidence
⚠️ Limitation
- ROCE (9.01%) and ROE (8.32%) remain weak
- P/E ratio higher than industry average
- Stock trading below DMA 50 and DMA 200, showing bearish trend
📉 Company Negative News
- Technical indicators (RSI 27.4, MACD -9.04) suggest weak momentum
- PEG ratio negative, reflecting poor growth outlook
📈 Company Positive News
- FII holdings increased (+1.26%) and DII holdings increased (+0.16%)
- Quarterly PAT improved sharply compared to previous quarter
🏭 Industry
- Sugar/engineering industry P/E: 11.1, lower than TRIVENI’s valuation
- Sector demand driven by cyclical consumption and industrial expansion
🔎 Conclusion
- TRIVENI is financially stable with improving profitability but weak efficiency metrics
- Valuation is slightly expensive compared to industry peers, with limited growth visibility
- Entry near 320–340 ₹ may offer value; suitable for long-term investors willing to accept cyclical risks